342 related articles for article (PubMed ID: 26100738)
1. 2014 in review: FDA approval of new drugs.
Kinch MS
Drug Discov Today; 2017 Apr; 22(4):620-624. PubMed ID: 26100738
[TBL] [Abstract][Full Text] [Related]
2. Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals.
Hao J; Rodriguez-Monguio R; Seoane-Vazquez E
PLoS One; 2015; 10(10):e0140708. PubMed ID: 26469277
[TBL] [Abstract][Full Text] [Related]
3. 2016 in review: FDA approvals of new molecular entities.
Griesenauer RH; Kinch MS
Drug Discov Today; 2017 Nov; 22(11):1593-1597. PubMed ID: 28687460
[TBL] [Abstract][Full Text] [Related]
4. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
DiMasi JA
Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
[TBL] [Abstract][Full Text] [Related]
5. 2018 in review: FDA approvals of new molecular entities.
Kinch MS; Griesenauer RH
Drug Discov Today; 2019 Sep; 24(9):1710-1714. PubMed ID: 31158510
[TBL] [Abstract][Full Text] [Related]
6. 2021 in review: FDA approvals of new medicines.
Kinch MS; Kraft Z; Schwartz T
Drug Discov Today; 2022 Aug; 27(8):2057-2064. PubMed ID: 35439613
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic transdermal drug innovation from 2000 to 2014: current status and outlook.
Walter JR; Xu S
Drug Discov Today; 2015 Nov; 20(11):1293-9. PubMed ID: 26116094
[TBL] [Abstract][Full Text] [Related]
8. Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999.
Cross J; Lee H; Westelinck A; Nelson J; Grudzinskas C; Peck C
Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):439-46. PubMed ID: 12426927
[TBL] [Abstract][Full Text] [Related]
9. 2015 in review: FDA approval of new drugs.
Kinch MS
Drug Discov Today; 2016 Jul; 21(7):1046-50. PubMed ID: 27109618
[TBL] [Abstract][Full Text] [Related]
10. 2020 in review: FDA approvals of new medicines.
Kinch MS; Kraft Z; Schwartz T
Drug Discov Today; 2021 Dec; 26(12):2794-2799. PubMed ID: 34252611
[TBL] [Abstract][Full Text] [Related]
11. U.S. Food and Drug Administration anticancer drug approval trends from 2016 to 2018 for lung, colorectal, breast, and prostate cancer.
Ribeiro TB; Ribeiro A; Rodrigues LO; Harada G; Nobre MRC
Int J Technol Assess Health Care; 2020; 36(1):20-28. PubMed ID: 31775939
[TBL] [Abstract][Full Text] [Related]
12. FDA new drug approvals in Q1 2020.
Urquhart L
Nat Rev Drug Discov; 2020 May; 19(5):299. PubMed ID: 32296148
[No Abstract] [Full Text] [Related]
13. Trends in pharmaceutical targeting of clinical indications: 1930-2013.
Kinch MS; Merkel J; Umlauf S
Drug Discov Today; 2014 Nov; 19(11):1682-1685. PubMed ID: 24881779
[TBL] [Abstract][Full Text] [Related]
14. Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008.
Moore TJ; Furberg CD
JAMA Intern Med; 2014 Jan; 174(1):90-5. PubMed ID: 24166236
[TBL] [Abstract][Full Text] [Related]
15. Availability of comparative efficacy data at the time of drug approval in the United States.
Goldberg NH; Schneeweiss S; Kowal MK; Gagne JJ
JAMA; 2011 May; 305(17):1786-9. PubMed ID: 21540422
[TBL] [Abstract][Full Text] [Related]
16. Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012.
Sacks LV; Shamsuddin HH; Yasinskaya YI; Bouri K; Lanthier ML; Sherman RE
JAMA; 2014 Jan 22-29; 311(4):378-84. PubMed ID: 24449316
[TBL] [Abstract][Full Text] [Related]
17. Regulatory watch: Efficiency indicators for new drugs approved by the FDA from 2003 to 2013.
Belleli R; Fisch R; Szucs TD
Nat Rev Drug Discov; 2015 Mar; 14(3):156. PubMed ID: 25722232
[No Abstract] [Full Text] [Related]
18. The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2020 Feb; 25(3):. PubMed ID: 32050446
[TBL] [Abstract][Full Text] [Related]
19. 2017 Is Banner Year for Drug Approvals by the Food and Drug Administration.
Ebied AM; Cooper-DeHoff RM
Am J Med; 2018 Sep; 131(9):1025-1033. PubMed ID: 29626430
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Trials Associated With Drugs Approved by the Food and Drug Administration in 2015 and 2016.
Eckert JC
Med Care; 2020 Mar; 58(3):194-198. PubMed ID: 32106163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
